These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9223023)

  • 1. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokinetics for functional dyspepsia.
    Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Leontiadis GI; Moayyedi P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009431. PubMed ID: 30335201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms].
    Fehr HF
    Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prokinetics in childhood].
    Gottrand F
    Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
    Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
    Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prokinetic therapy in gastroesophageal reflux disease.
    Champion MC
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.